Insider Selling: Afya (NASDAQ:AFYA) Insider Sells 4,161 Shares of Company Stock

Afya Limited (NASDAQ:AFYA) insider Santos Welder Ferreira sold 4,161 shares of Afya stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $13.30, for a total value of $55,341.30. Following the transaction, the insider directly owned 35,000 shares in the company, valued at approximately $465,500. This trade represents a 10.63% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Afya Stock Performance

NASDAQ AFYA traded up $0.60 on Tuesday, reaching $13.91. The stock had a trading volume of 247,503 shares, compared to its average volume of 149,659. The stock has a market cap of $1.30 billion, a P/E ratio of 8.48, a price-to-earnings-growth ratio of 1.37 and a beta of 0.34. Afya Limited has a 12-month low of $11.62 and a 12-month high of $16.16. The business’s 50-day moving average price is $13.79 and its 200 day moving average price is $14.26. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.20 and a current ratio of 2.20.

Afya (NASDAQ:AFYA) last announced its earnings results on Friday, August 14th. The company reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.03. The business had revenue of $187.80 million for the quarter, compared to analyst estimates of $189.62 million. Afya had a net margin of 20.55% and a return on equity of 17.58%. As a group, equities analysts expect that Afya Limited will post 1.86 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. Zacks Research downgraded Afya from a “hold” rating to a “strong sell” rating in a report on Friday, August 21st. Bradesco Corretora raised shares of Afya to an “outperform” rating and set a $17.00 price objective on the stock in a research note on Thursday, September 24th. JPMorgan Chase & Co. cut their price objective on shares of Afya from $21.50 to $21.00 and set a “neutral” rating for the company in a research report on Monday, June 22nd. Wall Street Zen upgraded shares of Afya from a “hold” rating to a “buy” rating in a research note on Saturday, September 5th. Finally, Bank of America reaffirmed a “neutral” rating on shares of Afya in a report on Thursday, June 11th. One research analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $17.75.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of AFYA. Engineers Gate Manager LP purchased a new position in Afya in the second quarter worth $325,000. Public Employees Retirement System of Ohio acquired a new stake in Afya in the second quarter valued at $67,000. Finally, Banco BTG Pactual S.A. purchased a new stake in shares of Afya during the 4th quarter worth $462,000. Institutional investors and hedge funds own 88.02% of the company’s stock.

Afya Company Profile

Afya Limited (NASDAQ: AFYA) is a Brazil-based medical education and health technology company. The company provides education and professional development for physicians and other healthcare professionals, with activities spanning undergraduate medical programs, medical residency preparation, specialization courses, continuing medical education and digital learning services.

Afya also develops technology-enabled products designed to support healthcare professionals throughout their careers.